Xeroderma pigmentosa with corneal involvement
Himalayan Journal of Ophthalmology · 2026-07 · 20 (2) · 111-113
DOI: 10.4103/hjo.hjo_40_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Himalayan Journal of Ophthalmology, online erschienen am 01.07.2026. Verfasst von Parri Muralidhar und 2 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder characterized by defective DNA repair, leading to extreme sensitivity to ultraviolet radiation and a high risk of cutaneous and ocular malignancies. This case report presents a case of a 14-year-old boy with XP who experienced photophobia along with significant ocular surface squamous neoplasia (OSSN). The patient’s family history indicated hereditary involvement. Ocular examination revealed OSSN, treated with topical 1% 5-fluorouracil (5-FU) four times daily for 1 week, followed by a 3-week drug holiday, repeated for three cycles. Significant improvement was observed in tumor size and ocular symptoms post-treatment. This case report highlights the effectiveness of 5-FU as a noninvasive, cost-effective alternative to other chemotherapeutic agents and surgical excision in managing OSSN in XP patients, emphasizing the importance of tailored treatment strategies and the necessity of long-term monitoring due to the ongoing risk of recurrence and malignancy.
Zitieren
APA
Muralidhar, P., Patil, G. R., & Devalla, M. D. (2026). Xeroderma pigmentosa with corneal involvement. Himalayan Journal of Ophthalmology, 20(2), 111-113. https://doi.org/10.4103/hjo.hjo_40_25
Vancouver
Muralidhar P, Patil GR, Devalla MD. Xeroderma pigmentosa with corneal involvement. Himalayan Journal of Ophthalmology. 2026;20(2):111-113. doi:10.4103/hjo.hjo_40_25
BibTeX
@article{Muralidhar2026,
author = {Muralidhar, Parri and Patil, Goudappa R. and Devalla, Mansi Dinesh},
title = {Xeroderma pigmentosa with corneal involvement},
journal = {Himalayan Journal of Ophthalmology},
year = {2026},
volume = {20},
number = {2},
pages = {111--113},
doi = {10.4103/hjo.hjo_40_25}
}
EUVIMED